A carregar...
Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
BACKGROUND: Type 2 diabetes mellitus is a progressive metabolic disease necessitating therapies with sustained efficacy and safety over time. Exenatide once weekly (ExQW), an extended-release formulation of the glucagon-like peptide-1 receptor agonist exenatide, has demonstrated improvements in glyc...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3555554/ https://ncbi.nlm.nih.gov/pubmed/23358123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S35801 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|